P -values in baseline tables of randomised controlled trials are inappropriate but still common in high impact journals

Abstract

Get full access to this article

View all access options for this article.

References

Davidson

Cockburn

Newton

Webster

Betihavas

Howes

. Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?. Eur J Cardiovasc Prev Rehabil 2010; 17: 393–402.

Senn

. Testing for baseline balance in clinical trials. Stat Med 1994; 13: 1715–1726.

Roberts

Torgerson

. Understanding controlled trials: baseline imbalance in randomised controlled trials. BMJ 1999; 319: 185–185.

http://www.consort-statement.org/consort-statement/13-19—results/item15_baseline-data/. (accessed August 2011).

Grobbee

Hoes

. Randomized trials. Clinical epidemiology. Sudbury, MA: Jones and Bartlett Publishers, 2009, pp. 270–287.

Altman

Dore

. Randomisation and baseline comparisons in clinical trials. Lancet 1990; 335: 149–153.

Assmann

Pocock

Enos

Kasten

. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355: 1064–1069.